We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTNE
551
CH4 Natural Solutions Corp
MTNE
$292M
| $17.7M | 0.02% |
+1,800,000
| New | +$17.8M |
|
552
Caesars Entertainment
CZR
$6.05B
| $17.7M | 0.02% |
+585,959
| New | +$16.5M |
|
553
Apollo Global Management
APO
$77.3B
| $17.6M | 0.02% |
149,100
-220,900
| -60% | -$27.8M |
|
|
SBXE
554
SilverBox Corp V
SBXE
$350M
| $17.6M | 0.02% |
1,750,000
| – | – |
|
555
Dow Inc
DOW
$21.2B
| $17.6M | 0.02% |
642,400
-400
| -0.1% | -$14.5K |
|
556
Alliant Energy
LNT
$17.6B
| $17.6M | 0.02% |
230,208
+203,900
| +775% | +$14.9M |
|
557
EastGroup Properties
EGP
$10.6B
| $17.5M | 0.02% |
86,436
-113,564
| -57% | -$22.7M |
|
|
CBLL
558
CeriBell Inc
CBLL
$937M
| $17.5M | 0.02% |
900,000
+143,249
| +19% | +$2.72M |
|
559
Dime Commercial Bancshares
DCOM
$1.78B
| $17.5M | 0.02% |
430,007
-215,073
| -33% | -$8M |
|
|
LADR
560
Ladder Capital
LADR
$1.24B
| $17.4M | 0.02% |
1,750,000
+650,000
| +59% | +$6.6M |
|
|
ALOV
561
Aldabra 4 Liquidity Opportunity Vehicle
ALOV
$374M
| $17.4M | 0.02% |
1,750,000
| – | – |
|
562
Legend Biotech
LEGN
$3.87B
| $17.3M | 0.02% |
+600,000
| New | +$16.2M |
|
563
Axalta
AXTA
$7.37B
| $17.1M | 0.02% |
500,000
-37,865
| -7% | -$1.14M |
|
564
Monro
MNRO
$392M
| $17M | 0.02% |
995,201
-553,069
| -36% | -$9.05M |
|
|
NINE
565
Nine Energy Service Inc
NINE
$137M
| $16.9M | 0.02% |
1,299,427
-55,722
| -4% | -$564K |
|
566
Fastenal
FAST
$56B
| $16.9M | 0.02% |
351,392
+184,600
| +111% | +$8.38M |
|
567
Equifax
EFX
$19.7B
| $16.8M | 0.02% |
106,100
-1,300
| -1% | -$222K |
|
568
ProQR Therapeutics
PRQR
$281M
| $16.8M | 0.02% |
9,015,897
+2,762,430
| +44% | +$4.55M |
|
569
Fidelity National Information Services
FIS
$19.6B
| $16.7M | 0.02% |
428,978
+30,200
| +8% | +$1.31M |
|
570
Trex
TREX
$4.63B
| $16.7M | 0.02% |
+333,000
| New | +$13.8M |
|
571
Ovid Therapeutics
OVID
$527M
| $16.6M | 0.02% |
6,163,781
| – | – |
|
572
Kimberly-Clark
KMB
$32.8B
| $16.5M | 0.02% |
150,645
+44,045
| +41% | +$4.37M |
|
573
Pan American Silver
PAAS
$21.9B
| $16.3M | 0.02% |
+365,000
| New | +$19.6M |
|
|
AVBH
574
Avidbank Holdings
AVBH
$345M
| $16.3M | 0.02% |
493,139
+41,104
| +9% | +$1.25M |
|
|
NVMI
575
Nova
NVMI
$11.9B
| $16.3M | 0.02% |
30,000
+15,000
| +100% | +$7.71M |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.